Assessing neurotoxicity from the low-dose radiation component of radiosurgery using magnetic resonance spectroscopy

Neuro-Oncology

Volumn 12, Issue 2, 2010, Pages 145-152

  Kelsey, Chris R ^a   Mukundan Jr , Srinivasan ^b   Wang, Zhiheng ^a   Hahn, Carol A ^a   Soher, Brian J ^a   Kirkpatrick, John P ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Magnetic resonance spectroscopy; Neurotoxicity; Spectroscopic imaging; Stereotactic radiosurgery

Indexed keywords

CHOLINE; CREATINE; N ACETYLASPARTIC ACID;

ADULT; AGED; ARTICLE; BRAIN ARTERIOVENOUS MALFORMATION; BRAIN METASTASIS; CLINICAL ARTICLE; FEMALE; HUMAN; LOW ENERGY RADIATION; MALE; MENINGIOMA; NEUROTOXICITY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; RADIATION DOSE; RADIATION INJURY; STEREOTACTIC RADIOSURGERY;

BRAIN; BRAIN NEOPLASMS; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; NEUROTOXICITY SYNDROMES; RADIOSURGERY;

EID: 75849142039     PISSN: 15228517     EISSN: 15235866     Source Type: Journal    
DOI: 10.1093/neuonc/nop040     Document Type: Article

References (38)

1. Wong CS, Van der Kogel AJ. Mechanisms of radiation injury to the central nervous system: implications for neuroprotection. Mol Interv. 2004;4:273-284.
2. Valk P, Dillon W. Diagnostic Imaging of Central Nervous System Radiation Injury. New York: Raven Press; 1991.
3. Virta A, Patronas N, Raman R, et al. Spectroscopic imaging of radiation-induced effects in the white matter of glioma patients. Magn Reson Imaging. 2000;18:851-857.
4. Holshouser BA, Tong KA, Ashwal S. Proton MR spectroscopic imaging depicts diffuse axonal injury in children with traumatic brain injury. AJNR Am J Neuroradiol. 2005;26:1276-1285.
5. Barker PB, Gillard JH, van Zijl PC, et al. Acute stroke: evaluation with serial proton MR spectroscopic imaging. Radiology. 1994;192:723-732.
6. Lanfermann H, Kugel H, Heindel W, Herholz K, Heiss WD, Lackner K. Metabolic changes in acute and subacute cerebral infarctions: findings at proton MR spectroscopic imaging. Radiology. 1995;196:203-210.
7. Fu L, Matthews PM, De Stefano N, et al. Imaging axonal damage of normal-appearing white matter in multiple sclerosis. Brain. 1998;121(Pt 1):103-113.
8. Baslow MH. N-Acetylaspartate in the vertebrate brain: metabolism and function. Neurochem Res. 2003;28:941-953.
9. 1H-MR spectroscopy of normal brain tissue before and after postoperative radiotherapy because of primary brain tumors. Int J Radiat Oncol Biol Phys. 2003;56:1381-1389.
10. Waldrop SM, Davis PC, Padgett CA, Shapiro MB, Morris R. Treatment of brain tumors in children is associated with abnormal MR spectroscopic ratios in brain tissue remote from the tumor site. AJNR Am J Neuroradiol. 1998;19:963-970.
11. 1H-MRSI of radiation effects in normal-appearing white matter: dose-dependence and impact on automated spectral classification. J Magn Reson Imaging. 2004;19:379-388.
12. 1H nuclear magnetic resonance spectroscopy in vivo. Int J Radiat Oncol Biol Phys. 1995;33:719-724.
13. Movsas B, Li BS, Babb JS, Fowble BL, Nicolaou N, Gonen O. Quantifying radiation therapy-induced brain injury with whole-brain proton MR spectroscopy: initial observations. Radiology. 2001;221:327-331.
14. Weitzner MA, Meyers CA, Gelke CK, Byrne KS, Cella DF, Levin VA. The Functional Assessment of Cancer Therapy (FACT) scale. Development of a brain subscale and revalidation of the general version (FACT-G) in patients with primary brain tumors. Cancer. 1995;75:1151-1161.
15. Cella DF, Tulsky DS, Gray G, et al. The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. J Clin Oncol. 1993;11:570-579.
16. Brucker PS, Yost K, Cashy J, Webster K, Cella D. General population and cancer patient norms for the Functional Assessment of Cancer Therapy-General (FACT-G). Eval Health Prof. 2005;28:192-211.
17. Fischer A, Holfelder H. Lokales amyloid im gehirn. Dtsch Z Chir. 1930;227:475-483.
18. Short SC, Kelly J, Mayes CR, Woodcock M, Joiner MC. Low-dose hypersensitivity after fractionated low-dose irradiation in vitro. Int J Radiat Biol. 2001;77:655-664.
19. Joiner MC, Marples B, Lambin P, Short SC, Turesson I. Low-dose hypersensitivity: current status and possible mechanisms. Int J Radiat Oncol Biol Phys. 2001;49:379-389.
20. Marples B, Wouters BG, Collis SJ, Chalmers AJ, Joiner MC. Low-dose hyper-radiosensitivity: a consequence of ineffective cell cycle arrest of radiation-damaged G2-phase cells. Radiat Res. 2004;161:247-255.
21. Blonder LX, Hodes JE, Ranseen JD, Schmitt FA. Short-term neuropsychological outcome following Gamma Knife radiosurgery for arteriovenous malformations: a preliminary report. Appl Neuropsychol. 1999;6:181-186.
22. Riva D, Pantaleoni C, Devoti M, Lindquist C, Steiner L, Giorgi C. Radiosurgery for cerebral AVMs in children and adolescents: the neurobehavioral outcome. J Neurosurg. 1997;86:207-210.
23. Wenz F, Steinvorth S, Wildermuth S, et al. Assessment of neuropsychological changes in patients with arteriovenous malformation (AVM) after radiosurgery. Int J Radiat Oncol Biol Phys. 1998;42:995-999.
24. Young RF, Shumway-Cook A, Vermeulen SS, et al. Gamma knife radiosurgery as a lesioning technique in movement disorder surgery. J Neurosurg. 1998;89:183-193.
25. Simmons ML, Frondoza CG, Coyle JT. Immunocytochemical localization of N-acetyl-aspartate with monoclonal antibodies. Neuroscience. 1991;45:37-45.
26. 1H magnetic resonance spectroscopy study. Magn Reson Med. 1995;33:595-600.
27. Bonavita S, Di Salle F, Tedeschi G. Proton MRS in neurological disorders. Eur J Radiol. 1999;30:125-131.
28. 1H MR spectroscopy in common dementias. Neurology. 2004;63:1393-1398.
29. Valenzuela MJ, Sachdev P. Magnetic resonance spectroscopy in AD. Neurology. 2001;56:592-598.
30. Briellmann RS, Wellard RM, Jackson GD. Seizure-associated abnormalities in epilepsy: evidence from MR imaging. Epilepsia. 2005;46:760-766.
31. Connelly A, Van Paesschen W, Porter DA, Johnson CL, Duncan JS, Gadian DG. Proton magnetic resonance spectroscopy in MRI-negative temporal lobe epilepsy. Neurology. 1998;51:61-66.
32. Kuzniecky R, Hugg JW, Hetherington H, et al. Relative utility of 1H spectroscopic imaging and hippocampal volumetry in the lateralization of mesial temporal lobe epilepsy. Neurology. 1998;51:66-71.
33. Arnold DL, Riess GT, Matthews PM, et al. Use of proton magnetic resonance spectroscopy for monitoring disease progression in multiple sclerosis. Ann Neurol. 1994;36:76-82.
34. Ende GR, Laxer KD, Knowlton RC, et al. Temporal lobe epilepsy: bilateral hippocampal metabolite changes revealed at proton MR spectroscopic imaging. Radiology. 1997;202:809-817.
35. Szigety SK, Allen PS, Huyser-Wierenga D, Urtasun RC. The effect of radiation on normal human CNS as detected by NMR spectroscopy. Int J Radiat Oncol Biol Phys. 1993;25:695-701.
36. Esteve F, Rubin C, Grand S, Kolodie H, Le Bas JF. Transient metabolic changes observed with proton MR spectroscopy in normal human brain after radiation therapy. Int J Radiat Oncol Biol Phys. 1998;40:279-286.
37. Chan YL, Roebuck DJ, Yuen MP, et al. Long-term cerebral metabolite changes on proton magnetic resonance spectroscopy in patients cured of acute lymphoblastic leukemia with previous intrathecal methotrexate and cranial irradiation prophylaxis. Int J Radiat Oncol Biol Phys. 2001;50:759-763.
38. 1H MR spectroscopy of mesial temporal lobe epilepsies treated with Gamma knife. Eur Radiol. 2003;13:994-1000.